Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 13/1/2021
SIETES contiene 93213 citas

 
 
 1 a 12 de 12 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Najafzadeh M, Andersson K, Shrank WH, Krumme AA, Matlin OS, Brennan T, Avorn J, Choudhry NK. Cost-effectiveness of novel regimens for the treatment of hepatitis C virus. Ann Intern Med 2015;162:407-19. [Ref.ID 98960]
2.Tiene citas relacionadas
Kesselheim AS, Misono AS, Shrank WH, Greene JA, Doherty M, Avorn J, Choudhry NK. Variations in pill appearance of antiepileptic drugs and the risk of nonadherence. JAMA Intern Med 2013;173:202-8. [Ref.ID 94940]
3. Cita con resumen
Choudhry NK, Fischer MA, Avorn JL, Lee JL, Schneeweiss S, Solomon DH, Berman C, Jan S, Lii J, Mahoney JJ, Shrank WH. The impact of reducing cardiovascular medication copayments on health spending and resource utilization. J Am Coll Cardiol 2012;60:1817-24. [Ref.ID 93132]
4. Cita con resumen
Choudhry NK, Avorn J, Glynn RJ, Antman EM, Schneeweiss S, Toscano M, Reisman L, Fernandes J, Spettell C, Lee JL, Levin R, Brennan T, Shrank WH, for the Post-Myocardial Infarction Free RX Event and Economic Evaluation (MI FREEE) Trial. Full coverage for preventive medications after myocardial infarction. N Engl J Med 2011;365:2088-97. [Ref.ID 91660]
5. Cita con resumen
Choudhry NK, Fischer MA, Avorn J, Liberman JN, Schneeweiss S, Pakes J, Brennan TA, Shrank WH. The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med 2011;171:814-21. [Ref.ID 91371]
6. Cita con resumen
Shrank WH. Our bulging medicine cabinets - The other side of medication nonadherence. N Engl J Med 2011;364:1591-3. [Ref.ID 90555]
7. Cita con resumen
Wolf MS, Curtis LM, Waite K, Bailey SC, Hedlund LA, Davis TC, Shrank WH, Parker RM, Wood AJJ. Helping patients simplify and safely use complex prescription regimens. Arch Intern Med 2011;171:300-5. [Ref.ID 90289]
8.Tiene citas relacionadas Cita con resumen
Shrank WH, Choudhry NK, Fischer MA, Avorn J, Powell M, Schneeweiss S, Liberman JN, Dollear T, Brennan TA, Brookhart MA. The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med 2010;153:633-40. [Ref.ID 89657]
9.
Choudhry NK, Shrank WH. Four-dollar generics - Increased accessibility, impaired quality assurance. N Engl J Med 2010;363:1885-7. [Ref.ID 89641]
10. Cita con resumen
Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brokhaart MA, Choudhry NK, Shrank WH. Clinical equivalence of generic and brand-name drugs used in cardiovascular diseases. A systematic review and meta-analysis. JAMA 2008;300:2514-26. [Ref.ID 84672]
11.Tiene citas relacionadas Cita con resumen
Avorn J, Shrank WH. Adverse drug reactions in elderly people. A substantial cause of preventable illness. BMJ 2008;336:956-7. [Ref.ID 82747]
12.
Shrank WH, Hoang T, Ettner SL, Glassman PA, Nair K, DeLapp D, Dirstine J, Avorn J, Asch SM. The implications of choice. Prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med 2006;166:332-7. [Ref.ID 76205]
Seleccionar todas
 
 1 a 12 de 12